Class Action Defense

Class Action Defense

Representative experience

  • Defense of Merck & Co. in three class actions concerning the pain relief drug Vioxx.
  • Defense of GlaxoSmithKline in class action litigation concerning the drug Avandia (indicated for diabetes type 2).
  • Defense of Eli Lilly & Co. in a class action litigation concerning the drug Zyprexa (indicated for schizophrenia and bipolar disorder).
  • Defense of Solbar Hatzor. in an NIS 112 million class action claim.
  • Defense of a large Israeli investment bank in a class action claim in the amount of NIS 60 million.
  • Defense of an accounting firm in an NIS 25 million class action for professional negligence.
  • Defense of a publicly traded company in a NIS 170 million class action alleging misrepresentation to investors.
  • Defense of a publicly traded company in a multi-million dollar class action alleging a violation of mandatory tender offer rules.
  • Defense of the Tel Aviv and Eilat municipalities in class actions alleging illegal collection of water and sewage fees.
  • Defense of the Israeli Yellow Pages in a class action claim regarding its business practices.

Practice area's Partners: